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Abstract
It is becoming increasingly clear that many diseases are the result of infection from multiple genetically distinct strains of a
pathogen. Such multi-strain infections have the capacity to alter both disease and pathogen dynamics. Infection with
multiple strains of human cytomegalovirus (HCMV) is common and has been linked to enhanced disease. Suggestions that
disease enhancement in multi-strain infected patients is due to complementation have been supported by trans-
complementation studies in mice during co-infection of wild type and gene knockout strains of murine CMV (MCMV).
Complementation between naturally circulating strains of CMV has, however, not been assessed. In addition, many models
of multi-strain infection predict that co-infecting strains will compete with each other and that this competition may
contribute to selective transmission of more virulent pathogen strains. To assess the outcome of multi-strain infection,
C57BL/6 mice were infected with up to four naturally circulating strains of MCMV. In this study, profound within-host
competition was observed between co-infecting strains of MCMV. This competition was MCMV strain specific and resulted
in the complete exclusion of certain strains of MCMV from the salivary glands of multi-strain infected mice. Competition was
dependent on Ly49H+ natural killer (NK) cells as well as the expression of the ligand for Ly49H, the MCMV encoded product,
m157. Strains of MCMV which expressed an m157 gene product capable of ligating Ly49H were outcompeted by strains of
MCMV expressing variant m157 genes. Importantly, within-host competition prevented the shedding of the less virulent
strains of MCMV, those recognized by Ly49H, into the saliva of multi-strain infected mice. These data demonstrate that NK
cells have the strain specific recognition capacity required to meditate within-host competition between strains of MCMV.
Furthermore, this within-host competition has the capacity to shape the dynamics of viral shedding and potentially select
for the transmission of more virulent virus strains.
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Introduction
It is becoming increasingly clear that many infections are caused
by multiple distinct strains of the infecting pathogen. A recent
review documented 51 infections of humans in which there is
definitive evidence of such multi-strain infection [1]. This is likely
to be an underestimation of the true rate of multi-strain infection,
given the technical difficulties associated with the detection of
more than one pathogen strain. Multi-strain infection has been
reported with many pathogen species including bacteria, protozoa,
helminths, fungi and viruses. In humans, multi-strain infection has
been demonstrated for a number of viruses including; HIV,
dengue virus, papillomavirus, hepatitis B, C, D and E viruses and
rotavirus (reviewed in [1]). Multi-strain infection appears to be
particularly common among the herpesviruses and has been
demonstrated for herpes simplex virus types 1 [2] and 2 [3],
Epstein Barr virus [4], varicella-zoster virus [5], human herpes-
virus 8 [6] and human cytomegalovirus (HCMV) [7,8].
HCMV, a member of the betaherpesvirus subfamily, is a large
double stranded DNA virus with a worldwide prevalence of 55–
100% depending on socioeconomic status and geographical
location. HCMV infection is life-long but is generally asymptom-
atic in the immunocompetent host. However in the immunocom-
promised individual HCMV can cause significant morbidity and
mortality. Despite the advent of antiretroviral therapy, AIDS
patients remain at risk of HCMV induced retinitis, uveitis and
vitritis [9]. HCMV has become the most common cause of
intrauterine viral infection in industrialized nations and causes
congenital abnormalities such as sensorineural hearing loss and
mental retardation [10]. For solid organ and bone marrow
allograft recipients, HCMV remains a major opportunistic
pathogen and causes post transplant complications including
vascular stenosis, CMV disease and organ rejection [11].
Infection with multiple strains of HCMV was first reported in
immunocompromised, HIV infected, individuals more than 25
years ago [7,8]. Since then a series of studies have documented
multiple HCMV infection in the immuno-suppressed or -
compromised including; patients with leukemia and lymphoma
[12,13], solid organ allograft recipients [14] and bone marrow
recipients [15]. Donor tissues including the kidneys [16,17] the
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heart [18], the liver [19] and the lungs [20] have all been shown to
transmit virus capable of re-infecting seropositive transplant
recipients. In the immunosuppressed, rates of multi-strain infection
can be high. In HIV infected patients, multi-strain HCMV
infection can be as high as 40–46% [21,22]. Even higher rates of
multi-strain infection have been documented in allograft trans-
plant recipients, with one study of lung transplant recipients
identifying multi-strain infection in 90% of patients [20]. The
number of individual infecting strains can also be high with up to 8
individual strains of HCMV detected in a single patient [23].
Multi-strain HCMV infection can also be found in normal
healthy individuals [24,25], indicating that neither immuno-
suppression nor transplant-acquired re-infection is needed for
the acquisition of multiple HCMV strains. In children
attending day care centers the rate of multiple infection can
be as high as 17%, with up to 6 different strains detected in
sequential sampling studies [26]. Four of eight women
attending an STD clinic were infected with multiple strains of
HCMV [25], while studies of tissues obtained from the
necropsy of 25 immunocompetent individuals identified multi-
strain infection rates of 20% [27]. Using strain specific serology
testing Ross and colleagues demonstrated re-infection rates of
29% in a cohort of 205 seropositive women [28]. In regions or
socioeconomic groups with high rates of seroprevalence, multi-
strain infection has been demonstrated in the majority of
infected individuals [29,30].
Theoretical and empirical studies suggest individual strains of
pathogen can participate in either positive (complementary) or
negative (competitive) interactions when co-infecting the same
host. These interactions can affect a range of medically relevant
outcomes such as: strain selection post vaccination, the spread of
drug resistance, genetic exchange and the evolution of virulence
(reviewed in [1]). Given the frequency with which individuals are
infected with multiple strains of HCMV, a full understanding of
the effects which multi-strain infection has on the pathobiology of
infection is required to fully understand treatment options, control
measures and diseases processes. For instance, complementary
interactions between viral strains have the obvious potential to
enhance disease severity. Several studies of immunosuppressed
allograft transplant recipients have linked multi-strain HCMV
infection to enhanced disease, elevated viral loads and reduced
organ survival [13,17,19,20,31,32]. Similarly, multi-strain infec-
tion in immunocompromised patients has also been linked to
enhanced CMV disease [13] or even accelerated progression to
AIDS in HIV infected individuals [21]. Primary infection reduces,
but does not protect from congenital disease, with morbidity seen
in infants born to mothers who were seropositive prior to
pregnancy (reviewed in [33]). While this could be due to viral
re-activation from latency, reinfection with novel strains of
HCMV can cause congenital disease [34,35] and has been linked
to enhanced fetal mortality [36].
Synergistic interaction amongst co-infecting strains of HCMV
may be a cogent explanation for the enhanced disease seen in
patients infected with multiple strains. However, not all studies
have demonstrated enhanced disease or viral loads in multi-strain
infected individuals. Complementation between co-infecting
strains of CMV has only been demonstrated in the mouse model
between gene knockout viruses and wild type strains of murine
CMV (MCMV) [37–39]. Complementation between naturally
circulating strains of CMV has not been assessed. Finally, it is not
clear that complementation, rather than competition or even
neutrality, will be the natural outcome of co-infection with
multiple strains of CMV. Indeed many theoretical models predict
that competition between strains of co-infecting pathogens is a
likely outcome of multi-strain infection, and perhaps more
importantly that such competition can lead to the evolution of
enhanced virulence (reviewed in [40]).
In order to investigate empirically the outcome of multi-strain
CMV infection we have developed a novel mouse model using
naturally circulating strains of MCMV. As with HCMV in
humans, multi-strain MCMV infection of free-living mice is
common [41,42]. The C57BL/6 (B6) mice used in this study show
resistance or susceptibility to MCMV infection based on the
expression of a single MCMV gene product, m157. B6 mice
express the NK cell activation receptor Ly49H, which recognizes
virally infected cells [43–45] via direct recognition of m157
[46,47]. However, strains of MCMV express different genotypes of
m157 [48,49], most of which are not recognized by Ly49H [50].
B6 mice are susceptible to infection with m157Ly49H2 strains of
MCMV but resistant to m157Ly49H+ strains [48,49]. The wild-
derived viruses used in the present study were all isolated from a
single wild-caught mouse [42] and are distinct strains as
determined by full genome sequencing [49,51].
We noted no evidence of within-host complementation, with no
enhancement of viral titers in mice receiving the mixed inoculum
compared to mice receiving a single strain infection. In marked
contrast profound, MCMV strain specific, within-host competition
was observed in B6 mice. During single strain infection all four
viral strains, C4A, C4B, C4C and C4D disseminated to and
replicated within the salivary glands of mice. However, during
multi-strain infection, both C4A and C4B were excluded from the
salivary glands, while C4C and C4D replicated normally at this
site. Functional studies demonstrated that the m157 protein
produced by both C4A and C4B ligated Ly49H, whereas C4C
and C4D m157 proteins failed to ligate this receptor. Subsequent
studies using Ly49H congenic mice, Ly49H blocking antibodies
and NK cell depletion studies demonstrated that within-host
competition was dependent on Ly49H+ NK cells. Competition
was also noted between K181 (m157Ly49H+) and C4C
(m157Ly49H2), but not between K181Dm157 (m157Ly49Hnull) and
C4C (m157Ly49H2), confirming a requirement for an m157
protein capable of binding Ly49H in the competition described
here. Within-host competition was complete and prevented the
shedding of m157Ly49H+ strains of MCMV into the saliva during
co-infection with m157Ly49H2 strains. Within-host competition
was evident as early as day three p.i. suggesting that NK cells
prevented the dissemination of m157Ly49H+ to the salivary glands.
Author Summary
Infection of the host with multiple strains of a pathogen is
common and occurs with the herpesvirus, human cyto-
megalovirus (HCMV). However the effects of multi-strain
infection on the host and the pathogen remain poorly
studied. Here we show, in a mouse model, that infection of
C57BL/6 mice with multiple strains of murine CMV (MCMV)
results in profound within-host competition. Competition
between the strains of MCMV is dependent on Ly49H+
natural killer (NK) cells. The NK cell activation receptor
Ly49H receptor targets certain genotypes of the viral
protein, m157. During multi-strain infection, strains of
MCMV encoding an m157 capable of binding Ly49H are
excluded from the salivary gland and the saliva of C57BL/6
mice, allowing for the shedding of only non-Ly49H binding
strains of MCMV in the saliva. This within-host competition
could therefore have significant impacts on the circulation
of MCMV strains, as only the most virulent MCMV strains
were present in the saliva.
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Therefore these studies demonstrate that NK cells are capable of
mediating competition between strains of MCMV and have the
potential to shape dissemination patterns of this virus.
Materials and Methods
Ethics statement
Experiments were performed with the approval of the Animal
Ethics and Experimentation Committee at the University of
Western Australia and in accordance with the guidelines of the
National Health and Medical Council of Australia.
Mice
Highly inbred, female BALB/cArc (BALB/c) and C57BL/
6JArc (B6) mice were obtained from the Animal Resource Centre
(Perth, Western Australia). The congenic mouse strains, BALB.B6-
Cmv1r and B6.BALB.TC1 (kindly provided by Dr. Anthony
Scalzo, Lions Eye Institute, University of Western Australia), were
bred at the Animal Services Facility, at the University of Western
Australia. All mice were infected at seven to eight weeks of age and
were maintained under specific pathogen free conditions prior to
and during experimentation.
Cells and cell lines
Primary mouse embryonic fibroblasts (MEF) were grown in
minimal essential media (MEM, HyClone, Thermo Scientific,
Logan, UT) supplemented with 8% newborn calf serum (NCS,
HyClone) and antibiotics (1 unit penicillin and 1 mg streptomycin/
ml (Invitrogen, Sydney)). The BWZ-HD12 reporter cells (kindly
provided by Dr. Anthony Scalzo) were grown in RPMI-1640
(Invitrogen) supplemented with 10% fetal bovine serum (FBS,
HyClone), antibiotics, 2 mM glutamine, 1 mM pyruvate, 50 mM
2-mercaptoethanol and 200 mg/ml hygromycin. Reporter assays
to measure the Ly49H binding capacity of individual MCMV
strains were performed as previously described [46]. Briefly,
56103 BALB/c derived MEF were added to each well of a flat
bottom 96 well tray in 16MEM supplemented with 2% NCS plus
antibiotics and incubated overnight at 37uC in 5% CO2. MEF
were infected with MCMV at a multiplicity of infection (MOI) of
0.5 by centrifugal enhancement. BWZ-HD12 reporter cells were
added to infected MEFs 24–48 hours later when cytopathic effect
in the infected MEF approached 100%. Infected MEF and
reporter cells were incubated overnight at 37uC in 5% CO2, with
the b-galactosidase production assessed eight hours after the
addition of 0.15 M chlorophenol red-ß-D-galactopyranoside
(CPRG). Chlorophenol red production was measured at a
wavelength of 570 nm, with 630 nm used as a reference
wavelength. Positive controls were 0.05 mg/ml PMA and
0.5 mg/ml ionomycin. K181 infected MEF were used as an
additional positive control, and uninfected MEF served as a
negative control.
The capacity of the MCMV strains used in this study to
replicate in MEF was assessed by multi-step growth curves analysis
as previously described [52]. The level of m157 on infected cells
was assessed by infecting MEF at a high MOI (.10) with C4A,
C4B, C4C, C4D or K181. MEF were stained 26 hours later with
anti-m157 antibody (6H121, provided by Wayne Yokoyama,
Washington University, School of Medicine) [53]. 6H121 conju-
gated to AlexaFluor647 was a kind gift of Dr Jerome Courdert,
(Lions Eye Institute, Western Australia). Levels of m157 on
infected MEF were assessed by gating on live cells (LIVE/DEAD
Fixable Near-IR Dead Cell Stain, Molecular Probes) and were
compared to uninfected cells.
Viruses and infection protocols
The MCMV strains C4A, C4B, C4C, and C4D were isolated
from a single free-living wild mouse, Mus musculus domesticus,
collected from a location near (C)anberra, Australian Capital
Territory, Australia and have been previously described [42,49].
Entire genome sequencing identified these viruses as distinct
strains of MCMV (Accession numbers; EU579861, HE610452,
HE610453, HE610456). K181Perth (hereafter referred to as K181)
has been described previously [54]. Viruses were propagated in
vitro on BALB/c MEF and were maintained as low passage stocks.
All in vivo experiments were performed with secondary salivary
gland derived virus stocks. These stocks were raised by two
passages of virus in weanling (three week old) female, B6 mice for
inoculation of B6 background mice, or in BALB/c mice for
inoculation of BALB/c background mice. Control, single strain
infected mice, were inoculated with 16104 pfu of virus via the
intraperitoneal (i.p.) route. Multi-strain infections were also given
via the i.p. route and comprised a mixed inoculum of up to four
different strains of MCMV, with each strain being an equal
fraction of the total 16104 pfu inoculum.
Construction of K181Dm157
K181Dm157 was produced by recreating the 104 bp spontaneous
loss-of-function mutation in m157 found upon serial in vivo passage
of K181 through Ly49H+ congenic mice [48]. Mutagenesis of
K181 to produce K181Dm157 was performed by ET recombination
as described [55]. For this we used the PCR primers; delta m157
forward TCTGGGACACACAAAGGATCTGCGTACGATA-
TGCATGTCTGTTTTTGGGAACGTCGTGGAATGCCTT-
CGAATTC and delta m157 reverse CCCGAACGTTGCTTTT-
TATCATATAGGTACCAATTTCTTTTGCGTCGGAAACA-
AGGACGACGACGACAAGTAA. PCR primers contain se-
quences specific for the plasmid pFLRTKn (underlined) and
sequence homologous to nt 216554–216603 and 216400–216449,
respectively in K181 (accession number AM886412). The K181
bacterial artificial chromosome (BAC), pARK25, used for
mutagenesis has been described [56]. The kanamycin resistance
gene used to select for successful recombinants was removed by
site-specific recombination using FLP recombinase expressed by
the plasmid pCP20 [55]. Successful deletion of the 104 bp of m157
in K181Dm157 was confirmed by sequence analysis (data not
shown). K181Dm157 replicated like wild type virus in vitro and failed
to stimulate the Ly49H reporter cell line BWZ-HD12 (data not
shown).
Virus determination in vivo
Viral titers in mice were determined by standard plaque assay
[57]. Briefly, organs were weighed and combined with 0.1 mg/ml
of 16MEM, supplemented with 2% NCS in a 2.0 ml safe lock
microcentrifuge tube with a 5 mm stainless steel bead. Organs
were homogenized using a Qiagen TissueLyser II set at a
frequency of 25 Hz for 2.5 minutes. Organ homogenates were
clarified by centrifugation at 425 rcf. Dilutions of homogenates
were added to confluent monolayers of MEF in 24 well tissue
culture plates. Virus and cells were co-incubated for 1 hour at
37uC and the virus was removed and the cells overlaid with 1 ml
of methylcellulose/16MEM supplemented with 2% NCS and
antibiotics. Plates were incubated for five days at 37uC in 5% CO2
to allow for plaque formation. Plaque assays were stopped after
five days with addition of methylene blue stain containing 5%
formaldehyde. After 24 hours the plates were washed, air-dried
and plaques counted by light microscopy, all titers are expressed as
plaque forming units (pfu) per gram of tissue.
NK Cell Dependent Within-Host Competition
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Viral genomes in the tissues of infected mice were quantified by
multiplex PCR. DNA was extracted from 10 mg of spleen, liver or
salivary gland using the Wizard Genomic DNA kit according to the
manufacturer specifications (Promega, Madison, Wisconsin). Prim-
ers, forward (59-ACAGGACGACCGAGTTCCCCG-39) and re-
verse (59-GTTGYACATCTAAGATCGAGAAACA-39) (Gene-
Works, Adelaide, South Australia) were used to amplify the
MCMV gene, m144. Strain-specific oligonucleotide probes were:
C4A (FAM-ATTCGAACCTGTTCACTGGCG-BHQ1), C4B
(HEX-CTTAGCTTCTTTTGACAGTCACGGTC-BHQ1) (both
obtained from GeneWorks), C4C (LC610-CAAAGCGGCGCAG-
CAACATAAC-BHQ1), C4D (LC670-TCCAAACCCCAAAC-
CAAAACCACGC-BHQ1) (Sigma-Aldrich, Castle Hill, New South
Wales) and K181 (FAM-CCTCAAACGTCAAAACAACAC-
CACGA-BHQ1) (GeneWorks). Reaction mix comprised 10 ml
Roche (Basel, Switzerland) 26Probes Master Mix and 500 nM
primers. Probes were used at a concentration of 250 nM for C4A,
K181, C4C and C4D and at 375 nM for C4B. A total of 100 ng
genomic DNA was added to each reaction mix. Cycling conditions
were as follows: 10 minutes 95uC, followed by 45 cycles each
consisting of 30 seconds at 95uC and 2 minutes at 66uC, and a final
cooling step to 50uC for 10 seconds. Concentrations of viral DNA
were calculated relative to an internal standard control using the fit-
points method on the LC480 software.
In vivo antibody treatments
To deplete NK cells, mice were treated at day 21, 0 and then
every five days with 150 mg of the antibody PK136 (anti-NK1.1).
On day 0, mice were co-infected with 0.56103 pfu C4A plus
0.56103 pfu C4C of salivary gland derived virus stock. Control
mice co-infected with C4A and C4C were treated with vehicle
(PBS) alone. Efficacy of NK cell depletion was assessed at day 18
post infection (p.i.) by flow cytometry of splenocytes using the pan
NK cell marker CD49b (clone DX5; BD Pharmingen, North
Ryde, NSW). PK136 treatment resulted in a 38% reduction in NK
cells relative to PBS treated mice. Ly49H blocking studies were
performed with the antibody 3D10 (anti-Ly49H), which was
provided by Professor Wayne Yokoyama (Washington University).
Mice were injected with 200 mg of 3D10 on day 22 and day 0 and
then every four days. On day 0 mice were infected as above with a
mixed inoculum of C4A and C4C. Control mice co-infected with
C4A and C4C were treated with isotype control antibody, 9E10
(anti-cMyc). All antibodies were supplied by WAIMR monoclonal
antibody facility (AbSolutions, WAIMR, Perth WA) as a protein G
affinity purified product.
Collection of saliva samples
Shedding of virus into the saliva was measured by collecting
saliva onto FTA paper (Qiagen, Doncaster, Victoria) [58]. A
1 mm2 punch was collected from air-dried, saliva impregnated
paper. The paper punch was then washed in 100 mM Tris, 0.1%
SDS for 30 minutes, then 5 M guanidine thiocyanate for
10 minutes, followed by three washes in sterile water for
10 minutes with a final 10 minute wash in 70% ethanol. Punches
were air dried and then loaded directly into PCR wells for analysis
by multiplex qPCR.
Statistics
One way analysis of variance (ANOVA) followed by Tukey’s
comparison was used to determine statistical significance between
multiple groups. Unpaired two tailed T tests were used to compare
between data from two groups. All statistical analyses were
performed using GraphPad Prism 5.0 (GraphPad Software, Inc,
California) with the values are expressed as mean 6 SEM.
Results
Multiple MCMV infection leads to competition in C57BL/6
mice
This study was designed to explore two potential consequences
of multi-strain CMV infection. These were, inter-strain comple-
mentation leading to enhanced viral loads in the tissues of infected
mice and within-host interactions, either complementary or
competitive, that affected the replication capacity of individual
strains. These outcomes were assessed by plaque assay and by
measuring strain prevalence using strain specific quantitative
PCR, respectively in B6 mice infected with up to four strains of
MCMV. The strains used, C4A, C4B, C4C and C4D were all
isolated from a single wild caught mouse and have been confirmed
as distinct strains by full genome sequence analysis [49,51].
Female B6 mice were infected with 16104 pfu of C4A, C4B,
C4C or C4D or with an equal mix of all four strains via the
peritoneal route. Viral titers were assessed 3 days later in the
spleen and the liver. Infectious virus was undetectable in the
spleens of C4A inoculated mice 3 days after infection, while titers
of virus in C4B infected mice were just above the limit of detection
(Figure 1A). In contrast, viral titers were 2.3610561.36105 and
8.6610464.36104 pfu/g tissue in the spleens of C4C and C4D
infected mice, respectively (Figure 1A). There was no evidence of
enhanced viral replication in the spleens of multi-strain infected B6
mice with titers significantly lower than those seen in C4C infected
mice and similar to those seen in C4D infected mice (Figure 1A).
The number of viral genomes detected in the spleens of infected
mice were equivalent for each MCMV strain irrespective of
infection protocol, with no enhancement of C4A or C4B viral
DNA levels in multi-strain (Figure 1C) compared to single strain
(Figure 1B) infected mice, and no enhancement or reduction in the
DNA load of C4C or C4D MCMV strains in multi- compared to
single- strain infected mice. Similar data were obtained in the
livers of mice three days p.i with no enhancement of viral loads
and no apparent interaction between the MCMV strains (data not
shown).
Despite low titers of C4A and C4B during acute single strain
infection, viral titers in the salivary gland of C4A and C4B singly
infected mice at day 18 p.i. were not significantly different to those
detected in C4C or C4D infected mice (Figure 1D). Moreover,
there was no enhancement of viral titers in the salivary glands of
multi-strain infected mice (Figure 1D). Mixed infection did
however, have a profound effect on within-host interactions. All
four MCMV strains were detectable in the salivary gland by
qPCR following single strain infection (Figure 1E). However after
co-infection with all four MCMV strains, C4A and C4B were
undetectable at this site (Figure 1F). Failure to detect C4A and
C4B at this site was not simply due to mixed infection per se, as
both these strains were able to disseminate to, and replicate within,
the salivary gland when administered together (Figure 1G).
However, in C4A and C4C co-infected mice, C4A DNA was
undetectable in the salivary gland of B6 mice (Figure 1H).
Therefore within-host competition was detected between MCMV
strains in a virus-strain specific manner.
Within-host competition is dependent on NK cells
Resistance of B6 mice to particular (m157Ly49H+) strains of
MCMV is due to the recognition of specific genotypes of the viral
m157 glycoprotein by host NK cells via the activation receptor
Ly49H [43–47]. These m157Ly49H+ strains of MCMV replicate
poorly in the spleen during acute infection [48], but show
prolonged replication in the salivary glands of B6 mice [59].
Strains that avoid Ly49H mediated immunosurveillance
NK Cell Dependent Within-Host Competition
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(m157Ly49H2) replicate well during acute infection but are more
rapidly cleared from the salivary glands of B6 mice [48,59].
Phylogenetic analysis of the m157 gene sequences from the C4
strains of MCMV suggested a possible mechanism behind viral
competition. The m157 genes of C4A and C4B co-segregated with
genotypes of m157 known to ligate Ly49H. In contrast, the m157
Figure 1. Competition is observed amongst co-infecting strains of MCMV in B6 mice. The outcome of multiple MCMV infection was
investigated in B6 mice during acute infection in the spleen (A–C) and persistent infection in the salivary glands (D–H). B6 mice were inoculated i.p.
with 16104 pfu of either a single MCMV strain (closed symbols) or a total of 16104 pfu of an mixed inoculum of up to four MCMV strains in equal
proportions (half filled diamonds - plaque assay or open symbols – strain specific PCR). A. Viral titers in the spleens of B6 mice 3 days after single
strain (closed symbols) or multi-strain (Mix - half filled diamond) infection. Titers of virus in C4C infected mice were significantly higher (p,0.05) than
in all other groups of MCMV infected mice. B. Viral DNA levels in the spleen of single strain infected mice from Fig. 1A. C. Viral DNA levels in the
spleen of multi-strain infected mice from Fig. 1A. D. Viral titers in the salivary glands of B6 mice 18 days after single strain (closed symbols) and multi-
strain infection (Mix - half filled diamond). E. Viral DNA levels in the salivary glands of single strain infected mice from Fig. 1D. Note despite low titers
in the spleen, both C4A and C4B replicate in the salivary glands of B6 mice. F. Viral DNA levels in the salivary glands of multi-strain infected mice from
Fig. 1D. Note during multi-strain infection both C4A and C4B were undetectable by qPCR in the salivary gland. G. B6 mice were co-infected with
16104 pfu of an equal mix of C4A and C4B and the levels of each virus assessed in the salivary glands of mice 18 days later by qPCR. Note both C4A
and C4B replicate at this site when co-inoculated together. H. B6 mice were co-infected with 16104 pfu of an equal mix of C4A and C4C, and the
levels of each virus assessed in the salivary glands of mice 18 days later by qPCR. Note C4A DNA was undetectable at this site in B6 mice co-infected
with both C4A and C4C. The x-axis represents the limit of detection for plaque assays (100 pfu/g of tissue) and the multiplex qPCR (16104 copy
number/g of tissue), n = 5 mice per group.
doi:10.1371/journal.ppat.1003111.g001
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genes of C4C and C4D co-segregated with m157 genes, shown by
others [48,50], to be incapable of ligating Ly49H (Figure S1).
To assess the role of Ly49H in within-host competition, the C4
strains of MCMV were tested for the capacity to ligate Ly49H
using the reporter cell line, BWZ-HD12 [46,48]. MEF infected
with either C4A or C4B activated the reporter cell line, while those
infected with C4C or C4D failed to activate BWZ-HD12 cells
(Figure 2A). All strains of MCMV replicated to similar levels in
MEF indicating that failure to ligate Ly49H was not due to
restricted replication in these cells (Figure 2B). Expression of m157
is low on infected cells and in this study could only be detected on
K181 infected MEFs (Figure S2). Failure to detect m157 on the
surface of MEF infected with the C4 strains of MCMV may reflect
the specificity of the anti-m157 monoclonal antibody (6H121)
which was raised against the Smith strain m157 [53]. Smith strain
m157 is identical to m157 from K181.
These data suggested that within-host competition in B6 mice
was mediated by NK cells. To test this hypothesis, B6 mice were
depleted of NK cells by treatment with anti-NK1.1 (PK136)
monoclonal antibody prior to and during co-infection with C4A
and C4C (Figure 3A, B). Figure 3A shows infectious viral titers in
non-manipulated B6 mice infected with C4A or C4C, and
infectious viral titers in mice co-infected with C4A and C4C and
treated with either PK136 or PBS. Depletion of NK cells restored
the capacity of C4A to replicate in the salivary gland during mixed
infection (Figure 3B). C4A was, however, excluded from the
salivary gland of co-infected mice treated with vehicle alone
(Figure 3C). These data indicate a requirement for NK cells in the
establishment of within-host competition. The same results were
obtained when the anti-NK1.1 treatment was applied on days 21
and 0 of infection only (data not shown).
Host Ly49H is required for within-host competition
To determine if Ly49H was required for within-host competi-
tion, multi-strain infection was assessed in mice congenic for the
natural killer cell complex (NKC). BALB.B6-Cmv1r mice (Cmv1r)
possesses the NKC from B6 mice on the BALB/c background
[60]. B6.BALB-TC1 mice (TC1) possess the NKC from BALB/c
mice on a C57BL/6 background [60]. We hypothesized that
within-host competition between C4A and C4C would occur in
Ly49H+ (B6 and Cmv1r) but not in Ly49H2 (BALB/c and TC1)
mice.
Both C4A and C4C replicated within the salivary glands of
Ly49H+ Cmv1r mice during single strain infection (Figure 4A,
Figure 2. Within-host dominance mirrors the capacity of MCMV strains to ligate Ly49H. A. Ly49H reporter cell assay. MEF were infected
with K181 (positive control) or the C4 strains of MCMV and used to stimulate the Ly49H reporter cell line BWZ-HD12. The percent maximal b-
galactosidase production was quantified relative to the PMA/ionomycin control (stippled bar). Both C4A and C4B stimulated b-galactosidase
production by reporter cells, whereas C4C and C4D infected cells failed to stimulate b-galactosidase expression. B. Multi-step growth curves for the
C4 strains of MCMV. MEF were infected with an MOI of 0.01 and replication rates assessed by plaque assay over a six day period. All viral strains
replicated to similar levels in MEF.
doi:10.1371/journal.ppat.1003111.g002
Figure 3. Within-host competition in B6 mice is dependent on NK cells. To assess the role of NK cell on within-host competition, NK cells
were depleted from B6 mice by i.p. injection of 150 mg of the monoclonal antibody PK136 at day21, 0 and then every 5 days until day 15 p.i. On day
0 mice were inoculated i.p. with 16104 pfu of either a single MCMV strain (closed symbols) or a total of 16104 pfu of a mixed inoculum of equal
proportions of C4A and C4C (half filled diamonds - plaque assay or open symbols – strain specific PCR). A. Titers of infectious virus were determined
by plaque assay in salivary glands of non-manipulated mice infected with either C4A or C4C (closed symbols), or in PK136 (anti-NK1.1) or PBS treated
mice co-infected with C4A and C4C (half filled diamonds). B. Viral DNA levels in B6 mice treated with PK136 (anti-NK1.1) and co-infected with C4A and
C4C. Note both C4A and C4C DNA were detectable following NK cell depletion. C. Viral DNA levels in B6 mice treated with vehicle (PBS) and co-
infected with C4A and C4C. Note competition was retained, with C4A DNA undetectable in the salivary glands. The x-axis represents the limit of
detection for plaque assays (100 pfu/g of tissue) and the multiplex qPCR (16104 copy number/g of tissue), n = 5 mice per group.
doi:10.1371/journal.ppat.1003111.g003
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plaque assay and Figure 4B qPCR). However, C4A was
excluded from the salivary glands of these Ly49H+ BALB/c
background mice during co-infection (Figure 4C). No compe-
tition was seen between these two strains of MCMV in Ly49H2
BALB/c mice (Figure 4D). Competition was not seen in B6
background Ly49H2 TC1 mice during co-infection (Figure 4G),
but was seen in Ly49H+ B6 mice (Figure 4H). Both C4A and
C4C were detectable in the salivary glands of TC1 mice during
single strain infection by plaque assay (Figure 4E) and by qPCR
(Figure 4F).
To confirm a role for Ly49H, B6 mice were treated with the
Ly49H blocking monoclonal antibody 3D10, and co-infected with
C4A and C4C (Figure 5A–C). Figure 5A shows infectious viral
titers in non-manipulated B6 mice infected with C4A or C4C and
infectious viral titers in mice co-infected with C4A and C4C and
treated with either monoclonal antibody 3D10 (anti-Ly49H) or
9E10 (anti-cMyc, isotype control). Competition was maintained in
isotype control treated mice, with only C4C detectable in the
salivary glands (Figure 5C). However, C4A and C4C were
detected (at equivalent levels) in the salivary glands of co-infected
B6 mice following anti-Ly49H antibody treatment (Figure 5B).
Taken together these data confirm an absolute requirement for
Ly49H, and therefore NK cells, in the with-host competition
between C4A and C4C in B6 mice.
MCMV strain competition is dependent on virally
encoded m157
Ly49H mediated competition should be mediated by its cognate
ligand, virally encoded m157. The MCMV strain K181 expresses
an m157 gene product known to ligate the product of the B6 allele
of Ly49h [61]. Serial passage of K181 through Ly49H expressing
congenic mice results in several different loss-of-function mutations
in m157. These mutations can be detected in some clones by
passage three and are seen in most clones by passage seven [48]. In
the study described here, a 104 bp region of m157 was deleted
from K181 to make K181Dm157, recreating one of the natural loss–
of-function mutations detected by Voigt and colleagues [48].
K181Dm157 replicated like wild type virus in vitro and failed to
activate Ly49H reporter cells (data not shown).
In vivo, titers of K181Dm157 in the salivary glands of B6 mice 18
days p.i. were higher than those of parental K181 infected B6 mice
and similar to those observed in C4C infected mice (Figure 6A).
Smith strain MCMV is more virulent following inactivation of
m157 [62]. This was also the case for K181. By day three p.i., B6
mice infected with C4C (n = 10) or K181Dm157 (n = 10) lost
significantly more weight than those infected with K181 (n = 10)
(p,0.001). Values are percentage weight loss from day 0 to day
3 p.i. and are mean 6 SD for: C4C 10.161.9, K181Dm157
12.561.9 and K181 (weight gain) +0.664.0.
Figure 4. The Cmv1r locus of the natural killer cell complex is linked to within-host competition. Congenic BALB.B6-Cmv1r (Cmv1r) or
B6.BALB.TC1 (TC1) mice were inoculated i.p. with 16104 pfu of either C4A or C4C (closed symbols) or co-infected with a total of 16104 pfu of C4A
and C4C (half filled diamonds - plaque assay or open symbols – strain specific PCR). B6 or BALB/c mice were co-infected with 16104 pfu of C4A and
C4C (open symbols). Viral replication was assessed by plaque assay at day 18 p.i. Strain specific replication was assessed by qPCR. A. Total viral loads
in the salivary glands of Cmv1r mice infected with C4A, C4C or C4A and C4C (half filled diamonds-Mix). B. DNA levels in the salivary glands of single
strain infected Cmv1r mice from Fig. 4A. C. Viral DNA levels in the salivary glands of multi-strain infected Cmv1r mice from Fig. 4A. D. Viral DNA levels
in the salivary glands of multi-strain infected BALB/c mice. Note competition was not seen in BALB/c mice, with both C4A and C4C equally well
represented in the salivary glands. However, in Ly49H+ BALB/c background mice (Cmv1r), C4A was excluded from the salivary glands during multi-
strain infection. E. Total viral loads in the salivary glands of TC1 mice infected with C4A, C4C or C4A and C4C (half filled diamonds-Mix). F. DNA levels
in the salivary glands of single strain infected TC1 mice from Fig. 4E. G. Viral DNA levels in the salivary glands of multi-strain infected TC1 mice from
Fig. 4E. H. Viral DNA levels in the salivary glands of multi-strain infected B6 mice. Note competition was not seen in Ly49H2 B6 background TC1 mice,
with both C4A and C4C equally well represented in the salivary glands. However, C4A was undetectable in the salivary glands of co-infected B6 mice.
The x-axis represents the limit of detection for plaque assays (100 pfu/g of tissue) and the multiplex qPCR (16104 copy number/g of tissue), n = 5–6
mice per group.
doi:10.1371/journal.ppat.1003111.g004
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The capacity of m157 to mediate competition was assessed in
B6 mice infected with either C4C and K181 or C4C and
K181Dm157. In B6 mice infected with C4C and K181, only C4C
DNA was detected in the salivary gland 18 days p.i. (Figure 6B).
These data indicate that competition between m157Ly49H2 and
m157Ly49H+ strains of MCMV is universal and not confined to
C4A or C4B. In B6 mice co-infected with C4C and K181Dm157,
DNA from both strains of MCMV was present in the salivary
gland (Figure 6C). These data demonstrate that Ly49H dependent
competition was also m157 dependent.
MCMV strain competition influences viral transmission
The ability of a particular pathogen strain to transmit from host
to host ultimately shapes the pathogen population and contributes
to overall virulence. Some theoretical models of multi-strain
infection predict that within-host competition has the potential to
shape the population structure of pathogens by selecting for
enhanced virulence (reviewed in [63]). The salivary gland is both
an organ of viral persistence as well as a major source of
transmission via shedding of virus into the saliva [64]. Within the
confines of this model, this means that only the more virulent
strains of MCMV (those that avoid Ly49H mediated immuno-
surveillance) should transmit.
To assess the likely effects of within-host competition on
transmission, saliva samples were collected on FTA paper from
infected mice (BALB/c, B6, Cmv1r and TC1) from day 12 p.i, and
viral DNA quantified by qPCR (Figure 7A–D). Both C4A and
C4C were present in nearly equal proportions in saliva samples
collected from Ly49H2 (TC1 and BALB/c) strains of mice
(Figure 7A, B). However, C4A DNA was undetectable in the saliva
of Ly49H+ (B6 and Cmv1r) mice (Figure 7C, D). Similar data were
obtained from B6 mice treated with Ly49H blocking antibody,
Figure 5. Blocking the NK cell receptor Ly49H eliminates viral competition. B6 mice were treated with 200 mg of the monoclonal antibody
3D10 (anti-Ly49H) or 200 mg of isotype control antibody 9E10 (anti-cMyc) on day22, 0, 4, 8, 12 and 16 of infection. On day 0 mice were inoculated i.p.
with 16104 pfu of either a single MCMV strain (closed symbols) or a total of 16104 pfu of a mixed inoculum of C4A and C4C (half filled diamonds -
plaque assay or open symbols – strain specific PCR). A. Titers of infectious virus were determined by plaque assay in salivary glands of B6 mice
infected with either C4A or C4C (closed symbols), or in anti-Ly49H or isotype control treated mice that were also co-infected with C4A and C4C (half
filled diamonds). B. Viral DNA levels in B6 mice treated with anti-Ly49H and co-infected with C4A and C4C. Note both C4A and C4C DNA were
detectable following anti-Ly49H treatment. C. Viral DNA levels in B6 mice treated with isotype control mAb and co-infected with C4A and C4C. Note
competition was retained in these mice with C4A undetectable in the salivary glands. The x-axis represents the limit of detection for plaque assays
(100 pfu/g of tissue) and the multiplex qPCR (16104 copy number/g of tissue), n = 5 co-infected mice/group, 3 single strain infected mice/group.
doi:10.1371/journal.ppat.1003111.g005
Figure 6. Within-host competition requires m157. A loss of function mutation was generated in the MCMV strain, K181, though the deletion of
104 bp in the m157 gene. B6 mice were inoculated i.p. with 16104 pfu of either C4C, K181 and or K181Dm157 (closed symbols) or inoculated with total
of 16104 pfu of a mixed inoculum of equal proportions of C4C and K181 or C4C and K181Dm157 (open symbols). A Salivary gland viral DNA levels in
single strain infected B6 mice 18 days p.i. B. Salivary gland viral DNA levels in C4C and K181 co-infected mice 18 days p.i. C Salivary gland viral DNA
levels in C4C and K181Dm157 co-infected mice 18 days p.i. Note K181 was excluded from the salivary glands when co-infected with C4C. However,
deletion of m157 restored the replication of K181 (K181Dm157) during multi-strain infection. The x-axis represents the limit of detection for the K181
qPCR (3.096105 copy number/g of tissue), n = 5 mice/group.
doi:10.1371/journal.ppat.1003111.g006
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with C4A and C4C DNA present in the saliva of these mice, while
only C4C DNA was detected in the saliva of mice treated with
isotype control antibody (data not shown).
To further investigate this effect on shedding and therefore
transmission, viral DNA levels were assessed in the saliva from
mice infected with C4C, K181 or K181Dm157 or during co-
infection with C4C and K181Dm157 or C4C and K181. To
determine at what stage of infection competition was first evident,
shedding of virus into the saliva was measured from day five p.i.
During single strain infection all three viruses were shed into the
saliva (Figure 7E). Likewise during co-infection with C4C and
K181Dm157 both viruses were shed into the saliva (Figure 7F). In
contrast, K181 was undetectable in the saliva of B6 mice during
co-infection with C4C (Figure 7G). Viral shedding into the saliva
was readily detectable by as early as day 10. Competition was well
established by this stage suggesting that competition was mediated
by a defect in dissemination rather than replication within the
salivary glands.
Within-host competition occurs early, prior to salivary
gland dissemination
MCMV replicates during acute infection predominantly in the
spleen and liver and disseminates to the salivary gland during a
viremic phase approximately 8 days p.i. Within-host competition
was apparent in the saliva by day 10 p.i. (Figure 7). Control of
viral replication within the salivary glands is not typically
associated with NK cell function. Competition was assessed at
day three p.i. to determine if NK cells prevented dissemination to
the salivary gland or if competition was due to events occurring at
this site. K181 was used in these studies as it replicates to higher
titres during acute infection in B6 mice than either C4A or C4B.
B6 mice were infected with C4C, K181, K181Dm157 or C4C
and K181 or C4C and K181Dm157. Surprisingly competition was
apparent in the spleen of B6 mice by day three p.i. While DNA
levels of K181Dm157 were significantly higher in the spleens of B6
mice than C4C during single strain infection (Figure 8A), DNA
from both viruses was detectable in this organ during co-infection
(Figure 8C). Therefore enhanced replication, K181Dm157 com-
pared to C4C, was not sufficient to promote competition between
strains of MCMV. In contrast, only C4C DNA was detectable in
the spleens of B6 mice co-infected with C4C and K181 (Figure 8B).
K181 DNA was however present in the spleen of B6 mice infected
with K181 alone (Figure 8A).
Viral titres in the spleen are more sensitive to inoculum size
than in the salivary glands, and the absence of K181 during multi-
strain infection could simply reflect the two-fold reduction in K181
inoculated into multi-strain infected mice. However, K181 DNA
levels in the spleens of B6 mice inoculated with 56103 pfu
(2.4.610761.36107 g/tissue) were not significantly different to
those in mice given an inoculum of 16104 pfu of K181
(5.4610761.86107 g/tissue). Moreover similar data were ob-
tained in a repeat experiment where single strain infected mice
were inoculated with 56103 pfu of either C4C, K181 or
K181Dm157 and multi-strain infected mice were inoculated with
a total of 16104 pfu of an equal combination of either C4C and
K181 or C4C and K181Dm157. In this instance single and multi-
strain infected mice received identical inoculums of each
individual MCMV strain. Despite this, competition was once
Figure 7. Within-host competition prevents viral shedding into the saliva. Shedding of C4A (open circles) and C4C (filled triangles) was
assessed during co-infection (a total of 16104 pfu of virus given i.p.) in A. TC1 mice, B. BALB/c mice, C. B6 mice and D. CMV1r mice. Note, both viruses
were present in the saliva of Ly49H2 (TC1 and BALB/c) mice, whereas C4A was excluded from the saliva of Ly49H+ (B6 and CMV1r) mice. The effect of
m157 on viral shedding was also assessed. B6 mice were infected with 16104 pfu of C4C, K181 or K181Dm157 or co-infected a total of 16104 pfu of
either C4C and K181Dm157 or C4C and K181. Shedding of virus into the saliva was assessed by qPCR E. Viral DNA in the saliva of mice infected with
C4C (filled triangles), K181 (filled squares) or K181Dm157 (filled circles). All three strains of MCMV were shed into the saliva during single strain infection.
F. Viral DNA in the saliva of mice co-infected with C4C (open triangles) and K181Dm157 (open circles). G. Viral DNA in the saliva of mice co-infected
with C4C (open triangles) and K181 (open squares). Note both C4C and K181Dm157 were shed into the saliva of B6 during co-infection, however K181
was excluded from the saliva when co-infected with C4C. Data are mean 6 SEM for 5 animals per group. Dotted line indicates limit of detection.
doi:10.1371/journal.ppat.1003111.g007
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again seen in C4C and K181 co-infected mice but not in C4C and
K181Dm157 co-infected mice (data not shown). Hence competition
is apparent in the spleens of multi-strain infected mice before the
maturation of acquired immunity and prior to dissemination to the
salivary glands.
In contrast to the spleen, competition was not seen in the liver of
B6 mice (Figure 8D–F). In this organ, both C4C and K181 were
present in co-infected mice (Figure 8E). Likewise both C4C and
K181Dm157 were present during multi-strain infection in the liver
(Figure 8F). Similar data were seen in a repeat experiment (data
not shown). Therefore, patterns of competition in the spleen and
liver exactly mirror the Ly49H mediated control of MCMV
infection in B6 mice, which is expressed in the spleen but not the
liver [57]. These data reinforce the central role of NK cells in
mediating competition in B6 mice.
Discussion
The Ly49H/m157 axis has provided many insights into the
interaction of mice with MCMV and also with more fundamental
aspects of immunology such as the potential of NK cells to exhibit
memory responses [65]. Here we have used this axis to probe the
outcome of multi-strain infection. In B6 mice, multiple-infection
with MCMV resulted in profound competition in which
m157Ly49H+ strains of MCMV failed to disseminate to, or
replicate within the salivary glands. Competition was not simply
a reflection of multi-strain infection as no competition was seen in
mice infected with only C4A and C4B, two m157Ly49H+ strains of
MCMV. Substitution of C4B with C4C (m157L49H2) resulted in
the establishment of competition, indicating that the genetics of
the co-infecting viral strains was important. NK cell depletion
using PK136 (anti-NK1.1) suggested a role for NK cells in
mediating within-host competition, however NK1.1 is also
expressed on natural killer T cells. NKC congenic mice were
used to demonstrate that competition among MCMV strains
occurred only in mice that naturally expressed or were congenic
for Ly49H. Antibody blocking studies supported an absolute
requirement for Ly49H, an NK cell specific receptor [66].
Deletion of m157 from K181, an m157Ly49H+ strain of MCMV,
removed competition during co-infection with the m157Ly49H2
strain C4C, indicating a requirement for m157 binding of Ly49H.
Finally, competition was rapid, prior to the maturation of acquired
immunity, and exactly mirrored the tissue distribution of Ly49H
immunosurveillance, with competition seen in the spleen but not
the liver [57].
Figure 8. Competition is evident early, before the maturation of acquired immunity. B6 mice were inoculated i.p. with 16104 pfu of either
C4C, K181 or K181Dm157 (closed symbols) or a total of 16104 pfu of a mixed inoculum of equal proportions of with C4C and K181 or C4C and
K181Dm157 (open symbols). A. Viral DNA levels in the spleens of B6 mice three days after single strain infection. B. Viral DNA levels in the spleens of
mice co-infected with C4C and K181. C. Viral DNA levels in the spleens of mice co-infected with C4C and K181Dm157 D. Viral DNA levels in the livers of
B6 mice three days after single strain infection. E. Viral DNA levels in the livers of mice co-infected with C4C and K181. F. Viral DNA levels in the spleen
of mice co-infected with C4C and K181Dm157. Note competition was evident in the spleen (B) but not in the liver (E). Data are mean 6 SEM for 5
animals per group. Dotted line indicates limit of detection. DNA levels in mice following single strain infection were compared by one-way Anova,
asterisks indicate level of significance after Tukey’s post hoc analysis (*** P,0.001, ** P,0.01, * P,0.05).
doi:10.1371/journal.ppat.1003111.g008
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The rapidity at which m157Ly49H+ strains of MCMV were
excluded from the salivary glands suggests that NK cells mediate
this competition by preventing the dissemination of MCMV to the
salivary glands. This hypothesis is consistent with the rapid
competition observed in the spleen but appears at odds with the
lack of competition seen in the liver. Presumably virus from the
liver (and perhaps other organs) could serve as a reservoir for viral
dissemination to the salivary gland. However, the origin of
MCMV colonizing the salivary glands is unclear. The established
paradigm is that infecting virus replicates at the site of entry and
then later in secondary organs before final dissemination to the
target organ [67]. For MCMV this is in the peritoneal cavity,
when injected via this route, which leads to a primary viremia and
dissemination of the virus to the spleen and liver. This is then
followed by a secondary viremia and dissemination of the virus to
the salivary gland from which it is transmitted to a new host [68].
However this picture of CMV dissemination has recently been
challenged. Sacher and colleagues (2008) demonstrated that
hepatocytes, the major producer of virus in the liver, were not
the source of MCMV in the salivary glands [69]. Whilst the origins
of virus in the salivary glands is therefore unclear, the data
presented here support the proposition that NK cells mediate
entirely the competition seen in this model. Moreover, they
prevent the dissemination of MCMV to the salivary gland, and in
doing so prevent transmission of m157Ly49H+ strains of MCMV
during multi-strain infection.
The ‘‘apparent competition’’ (competition mediated by host
immunity) seen in this model has been predicted to be important
in shaping interactions amongst co-infecting pathogen strains
[1,63]. Apparent competition between strains of pathogen can be
mediated by adaptive immunity, such as that seen between strains
of Plasmodium chabaudi [70] or by innate immunity, such as that
seen between encapsulated and non-capsulated strains of Strepto-
coccus pneumonia during co-infection with Haemeopilus influenzae [71].
Here we show for the first time that NK cells, due to strain specific
recognition, can mediate within-host competition. Moreover we
identify the exact molecular mechanism that leads to within host
competition, that being the Ly49H/m157 axis.
Transmission of pathogens from one host to another is
ultimately the most important aspect of pathogen of behavior.
Here we have demonstrated that competitive interactions amongst
co-infecting strains of MCMV have the capacity to influence
which strains are transmitted. For CMV, the salivary gland is an
important organ for viral persistence and transmission [64]. In B6
mice competition between m157Ly49H+ and m157Ly49H2 MCMV
strains resulted in the exclusion of m157Ly49H+ strains from the
saliva. Avoidance of Ly49H mediated immunosurveillance leads to
enhanced virulence of MCMV in B6 mice as measured by higher
viral titers and enhanced morbidity (data described herein and
[62]). Within-host competition therefore leads to selective shed-
ding of the more virulent strain of MCMV. These data fit
theoretical models which predict that within-host competition will
drive the evolution of virulence by selecting for transmission of
more virulent pathogen strains (reviewed in [1]). Virulence in these
models is often ascribed to pathogen replication rates. Here
virulence is linked to avoidance of a dominant host control
mechanism.
Mutation of m157 following passage in Ly49H+ mice is a
potential mechanism for the evolution of this viral gene [48,72].
Here we show another potential mechanism for the loss of specific
viral genotypes from the population that does not require mutation
and loss of function. Since multi-strain MCMV infection is
common in free-living mice [41,42] this may be a powerful
mechanism for the selection of non-Ly49H binding genotypes of
m157. In populations of mice where Ly49h and multi-strain
infection is common these data would predict rapid loss of
m157Ly49H+ strains of MCMV from the population. Under these
circumstances there may be a reduced role for mutational
inactivation of m157. This would permit the retention of m157
function and allow for continued targeting of inhibitory Ly49
molecules [47,50] by MCMV. When Ly49H mediated selection of
m157 mutations following serial viral passage have been demon-
strated, the vast majority of these mutations are frame shift
mutations, premature stop mutations or deletions in the hydro-
phobic tails [48,72]. These types of mutations are not apparent in
the m157 gene sequences from the 36 different MCMV strains so
far deposited in DNA databases. Importantly, this suggests that
mutation of m157 is not generally required for the removal of
m157Ly49H+ genotypes from a population, and that multi-strain
infection can lead to rapid (within a single passage) loss of these
genotypes without inactivation of the m157 gene.
The capacity of NK cells to shape the population dynamics of
CMV infection may not be limited to the effects of Ly49H and
m157, as NK cell targeting of specific viral proteins is not confined
to the Ly49H/m157 axis. In BALB.K mice resistance to MCMV
is due to Ly49L+ NK cells, and these cells proliferate in response to
MCMV infection as is seen for Ly49H+ NK cells in B6 mice [73].
In BALB.K mice, Ly49L+ NK cells specifically respond to MCMV
encoded m04 [73]. Like m157, m04 varies between strains of
MCMV [49,74,75] allowing for the possibility that genes other
than m157, and NK cells other than those expressing Ly49H,
could shape within-host interactions between strains of MCMV.
Humans also encode a series of polymorphic inhibitory and
activating NK cell receptors called killer cell immunoglobulin-like
receptors (KIR) which are functionally analogous to the mouse
Ly49 family [76]. While activating receptors recognizing HCMV
encoded ligands have not been demonstrated, HCMV seropositive
individuals have higher levels of circulating CD94/NKG2C+ NK
cells [77–79] which expand rapidly after acute HCMV infection
or reactivation in transplant recipients [80,81]. Furthermore, like
MCMV encoded m04 and m157, HCMV expressed targets of NK
cells such as UL18 [77,78] also vary between viral strains [79].
Therefore it is possible that NK cells will also be able to mediate
strain specific recognition of HCMV which would provide the
basis for NK cell mediated within host competition during multi-
strain HCMV infection. Interestingly, strains of HCMV are
known to vary in prevalence during longitudinal studies in infected
individuals [23] suggesting stochastic reactivation from latency - as
suggested by the study authors - or perhaps competition between
the strains. The studies described here provide a paradigm for
testing the roles of NK cells in shaping competition between strains
of pathogens where multi-strain infection is common.
The mechanisms through which Ly49H mediated immunosur-
veillance drives such profound competition and control of
m157Ly49H+ strains of MCMV only during multi-strain infection
remain unclear. However it is possible that multi-strain infection
alters the amplitude or duration of NK cell responses. Perhaps,
during multi-strain infection type I interferons or cytokines such as
IL-12 and IL-15 are maintained at higher levels in response to the
continued presence of m157Ly49H2 strains of MCMV. This could
result in either an enhanced expansion of the Ly49H+ NK cell
pool or a delay in the contraction phase [80]. Alternatively,
prolonged or enhanced expression of these cytokines may
modulate either the recruitment of naı¨ve NK cells [81] into the
activated pool of NK cells or moderate the ‘‘anergy’’ seen in
Ly49H+ NK cells following repeated stimulation through this
receptor [82,83]. The rapidity of the competition, as noted in the
spleen, suggests that alterations to NK cell responses must be
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rapid. However, it is likely that altered NK cell responses may also
be prolonged and required for the prevention of dissemination
from other organs not assessed in this study.
In summary our data demonstrate that NK cells have the strain
specific recognition capacity to meditate within-host competition
between strains of MCMV. This competition has the capacity to
shape the dynamics of viral shedding, and to select for the more
virulent strains of MCMV that avoid Ly49H mediated immuno-
surveillance. This within-host competition provides a potential
mechanism for the rapid removal of m157Ly49H+ binding strains of
MCMV from a population without the need for mutational
inactivation of the m157 gene.
Supporting Information
Figure S1 Phylogenetic analysis of published m157
sequences. Sequences of m157 were extracted from DNA
databases or produced in this study and used to construct a
maximum likelihood phylogeny. Shown in red are m157
genotypes that have been shown to encode products capable of
ligating Ly49H. In green are genotypes that produce products that
do not ligate Ly49H. Genotypes in black have not been tested.
Functional data was obtained from publications 48 and 50 and
data described herein.
(EPS)
Figure S2 Surface expression of m157 on infected MEF.
MEF were infected with high MOI (.10) and stained for surface
expression of m157 using the monoclonal antibody 6H121. 6H121
was raised against the Smith/K181 variant of m157. Uninfected
cells (grey shading) were used as controls. Note m157 was only
detectable on the surface of MEF infected with K181, solid black
line – last histogram. Surface expression of m157 was not
detectable on C4A, C4B, C4C or C4D (grey lines – order is front
to back) infected cells.
(EPS)
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